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Background: High rates of volume overload hospitalizations may indicate inadequate dialysis facility fluid
management. Administrative claims databases are often used to study such outcomes, but these data are
generated for billing purposes and may not capture clinical nuance. It is unknown if volume overload admissions
can be correctly identified in administrative data and if a single claims-based definition for volume overload can be
used across epidemiologic surveillance studies, observational studies of exposure-outcome associations and quality
assessments. We conducted a validation study to assess the accuracy of claims-based definitions for volume
overload hospitalizations among hemodialysis patients.
Methods: Data were taken from a random sample of 315 adult hemodialysis patients admitted to University of North
Carolina Hospitals from January 2010 through June 2013. Standardized chart reviews were conducted to clinically
adjudicate the presence or absence of volume overload at hospital admission. Claims-based definitions were
constructed from varying combinations of fluid-related ICD-9 discharge diagnosis codes including fluid overload,
pulmonary edema, pleural effusion, and heart failure. Using clinically adjudicated volume overload hospitalizations as
the reference standard, validity metrics and their 95 % confidence intervals (CIs) were estimated for each definition.
Results: Of the 315 hospital admissions, 77 (24.4 %) were clinically adjudicated as volume overload hospitalizations.
The prevalence of claims-identified volume overload admissions varied across definitions, ranging from 1.6 to 37.1 %.
When definitions were constructed with discharge diagnosis codes present in any billing position, volume overload
hospitalizations defined by fluid overload, pleural effusion or heart failure diagnosis codes had the highest sensitivity,
81.8 % (95 % CI: 71.4 %, 89.7 %). Volume overload hospitalizations defined by pulmonary edema diagnosis codes had
the highest specificity, 98.3 % (95 % CI: 95.8 %, 99.5 %). Definitions constructed with discharge diagnosis codes present
in any billing position (versus the primary position) captured more false positive events.
Conclusions: Prevalence and validity estimates of volume overload hospitalizations vary across claims-based
definitions. A universal claims-based definition for volume overload hospitalizations may not apply to all clinical and
research scenarios. Investigators and regulators need to consider the implications of misclassifying events when
evaluating and monitoring hemodialysis patient volume overload admissions with administrative data. Claims-based
definitions should be selected accordingly.
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The over 400,000 individuals receiving hemodialysis in the
United States (U.S.) have exceedingly high rates of cardio-
vascular morbidity and mortality, with 30 % of hospitaliza-
tions and nearly 50 % of deaths attributed to cardiovascular
causes [1]. Care of this complex population is expensive. In
2011, persons with end-stage kidney disease represented
just 1.4 % of Medicare enrollees but consumed 6.3 % of the
total Medicare budget [2]. Inadequate volume control is
associated with both adverse cardiovascular outcomes and
substantial healthcare costs among hemodialysis patients
[3–5]. Volume-related hospital admissions are a significant
driver of the cardiovascular hospitalization rate in the
hemodialysis population, and estimated annual costs related
to these encounters total over $250 million [1, 6].
Some volume overload hospitalizations may be prevent-
able with better dialysis facility fluid management practices.
For example, close attention to prescribed target (“estimated
dry”) weight achievement at the end of each dialysis treat-
ment as well as delivery of effective dietary salt and fluid
restriction counseling by dialysis unit personnel may prevent
some volume-related complications [4, 7, 8]. Tracking
volume overload hospitalizations represents one potential
strategy to measure and assess dialysis facility fluid manage-
ment practices. The Medicare-based United States Renal
Data System (USRDS), a national registry of end-stage
kidney disease patients, is a readily available and cost effec-
tive data source often used to monitor and study cause-
specific hospitalizations in the U.S. hemodialysis population.
Administrative claims data, such as that housed in the
USRDS, are primarily generated for reimbursement and
billing purposes. These data may not always capture
clinical subtleties, potentially affecting the accuracy of
claims-identified, cause-specific hospital admissions. For
example, general population validation studies suggest that
~25 % of true heart failure hospitalizations are not cap-
tured by administrative claims data [9]. Prior evaluations of
volume overload hospitalizations among hemodialysis
patients were performed using USRDS data, each relying
upon distinct combinations of discharge diagnosis and/or
procedure codes to define events [6, 10, 11]. However, the
validity of these claims-based definitions is unknown. In
the medically complex hemodialysis population, restric-
tions on the number of diagnosis and procedure codes that
can be billed per inpatient encounter, among other factors,
may influence the ability of investigators to accurately
identify cause-specific hospitalizations in administrative
data. As such, when choosing claims-based volume over-
load definitions for observational studies, investigators
must consider the implications of outcome misclassifica-
tion and appropriately prioritize validity metrics (e.g. sensi-
tivity and specificity) to optimize study accuracy. Study
objectives and corresponding study design should guide
claims-based outcome definition selection.We undertook this study to evaluate the validity of sev-
eral claims-based definitions for volume overload hospital
admissions in the hemodialysis population using rigorous
medical record reviews and medical center billing data.
Methods
Study population
This study included a random sample of 315 unique, adult
maintenance hemodialysis patients admitted to University
of North Carolina (UNC) Hospitals (Chapel Hill, NC)
between January 1, 2010 and June 30, 2013. UNC
Hospitals is a public academic medical center with over
800 inpatient beds and over 35,000 annual discharges. The
study cohort consisted of hemodialysis patients who were:
1) ≥18 years of age and 2) admitted to medical or surgical
services. We excluded patients who were: 1) receiving
home hemodialysis or peritoneal dialysis or 2) newly
designated as end-stage renal disease during the sampled
admission. We selected 2010 as the study start year in
order to exclude hospital admissions occurring before the
Medicare policy change expanding the maximum number
of billable discharge diagnoses per inpatient claim from 9
to 25 [12].
We performed a priori sample size calculations. Assum-
ing a 20 % prevalence of volume overload admissions [1],
a sample size of 298 patients would be needed to estimate
a minimum specificity of 70 % with an acceptable lower
95 % confidence interval (CI) of at least 60 % [13]. This
study was approved by the UNC Chapel Hill Institutional
Review Board.
Data sources
Overview
Data were obtained from the Carolina Data Warehouse for
Health (CDW-H), a central data repository containing ad-
ministrative healthcare data sourced from the UNC Health
Care System. Detailed clinical data are not captured in this
database and were abstracted from the electronic medical
record by three clinicians (M.M.A., T.N. and S.L.K.).
Clinical adjudication of volume overload hospital admissions
For each sampled hospitalization, we conducted detailed
clinical chart reviews to adjudicate the presence or
absence of volume overload at the time of admission.
We sought to identify hospitalizations of patients admit-
ted with volume overload. Unlike other cardiovascular
conditions, such as myocardial infarction, there is no
established, objective definition for the clinical diagnosis
of volume overload. Volume overloaded hemodialysis
patients often present with a constellation of signs and
symptoms indicative of fluid retention (e.g. shortness of
breath, rales on lung auscultation, pulmonary edema on
chest imaging, etc.) that may vary from individual to in-
dividual. Thus, an in-depth review of the medical record
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findings associated with each sampled hospitalization.
Medical chart notes (e.g. emergency department, admit-
ting team and consult notes), chest and abdominal
imaging reports, and cardiac procedure reports occurring
within 24 h of admission were evaluated. Abstractors
utilized a standardized data collection form (Additional
file 1) to record symptoms, physical exam findings,
imaging results, and clinical impressions. Each medical
record was independently abstracted by two clinical
reviewers who were blinded to the hospitalization’s billed
diagnosis and procedure codes and to the abstraction
results of the other reviewer. Inter-abstractor discrepan-
cies in individual data elements were resolved by a board-
certified nephrologist (J.E.F) Initial agreement between
abstractors was high across all data elements, ranging
98.1 % (κ = 0.91) for subjective dyspnea to 100 % (κ = 1.00)
for central venous pressure. After review and error reso-
lution, consensus was reached on all abstracted charts.
We created a standardized diagnostic algorithm to
determine the presence or absence of volume overload at
the time of admission based on the American College of
Cardiology Foundation/American Heart Association and
European Society of Cardiology guidelines [14, 15], and
input from local nephrologists and cardiologists (Fig. 1).
Diagnostic algorithm pre-testing revealed that a clinicalFig. 1 Reference standard criteria for adjudication of volume
overload hospital admissions. Documented clinical assessment and
physician impression criteria occurring within 24 h of admission
were considered. Hospitalization events were adjudicated as volume
overload admissions if either the clinical assessment criteria or
physician assessment criteria for volume overload were met.
Hospitalization events were adjudicated as non-volume overload
admissions if they did not meet the physician impression criteria
and did not meet the clinical criteria for volume overloadcriteria-based algorithm (e.g. symptoms, physical exam
findings, and imaging results) failed to capture emergent
presentations of volume overload requiring immediate
treatment. In severe cases, imaging was not always
performed prior to treatment (e.g. ultrafiltration). To cap-
ture such events, we expanded the algorithm to include
clinical criteria or physician impression of volume over-
load. Furthermore, our diagnostic algorithm was devel-
oped to capture a range of volume overload severities. By
design, our clinical definition does not distinguish patients
admitted for the indication of volume overload from
patients admitted with volume overload. Both scenarios
were identified by our algorithm as clinically adjudicated
volume overload events.
We applied the diagnostic algorithm to the abstracted
data. Hospitalizations were adjudicated as volume over-
load admissions if either the clinical assessment criteria
or the physician impression criteria for volume overload
were met. Otherwise, hospitalizations were adjudicated
as non-volume overload admissions. Agreement between
volume overload admissions identified by clinical assess-
ment criteria and admissions identified by physician im-
pression criteria was high, 91.4 % (κ = 0.73).
Administrative claims-based definitions for volume overload
hospital admissions
We obtained administrative data including demographics,
billed hospital discharge diagnoses and procedure codes
from the CDW-H for each sampled admission. We evalu-
ated a range of administrative claims definitions for
hospitalized volume overload. Definitions were constructed
based upon literature precedent using various combinations
of fluid overload, pulmonary edema, pleural effusion and
heart failure International Classification of Diseases, Ninth
Revision (ICD-9) discharge diagnosis codes (Table 1 and
Additional file 2: Table S1) [6, 10, 11]. Primary validation
analyses considered discharge diagnosis codes present in
any position. Secondary analyses considered discharge
diagnosis codes present in the: 1) primary billing position
only and 2) primary or leading secondary billing position
(separately). In additional secondary analyses, we evaluated
the validity of claims-based volume overload definitions
that included both fluid-related discharge diagnosis codes
and the presence of a dialysis Current Procedural Termi-
nology (CPT) procedure codes billed on the day of
admission or the following day (Additional file 2: Table S2)
[6]. The Medicare requirement of attending presence
during in-hospital dialysis treatments for the billing of
dialysis CPT codes may lead to inaccurate estimates of
inpatient dialysis procedures in administrative data sources
[16]. In our cohort, of the 59 clinically adjudicated cases
who received dialysis within 24 h of admission (per medical
chart documentation), only 39 (66.1 %) had a corres-
ponding billed dialysis CPT procedure code. To avoid
Table 1 Administrative claims-based definitions for volume overload hospital admissions
Definition number and description Lead author (year of publication)a ICD-9 discharge diagnosis codesb
1. Fluid overloadc Banerjee (2007) [10] 276.6, 276.69
2. Pulmonary edema – 514, 518.4
3. Heart failure – 398.91, 402.x1, 404.x1, 404.x3, 428d
4. Fluid overloadc or pulmonary edema – 276.6, 276.69, 514, 518.4
5. Fluid overloadc or pleural effusion Weinhandl (2015) [11] 276.6, 276.69, 511.9
6. Fluid overloadc or heart failure – 276.6, 276.69, 398.91, 402.x1, 404.x1, 404.x3, 428d
7. Fluid overloadc, pulmonary edema or heart failure Arneson (2010) [6] 276.6, 276.69, 514, 518.4, 402.x1, 404.x1, 404.x3, 428d
Abbreviations: ICD-9 International Classification of Diseases, Ninth Revision
aDenotes prior use of the ICD-9 diagnosis code combination to define volume overload hospitalizations
bSeparate analyses evaluating definition validity considered ICD-9 diagnosis codes present in: 1) any billing order position, 2) the primary billing position only and 3)
the primary and leading secondary billing positions
cPrior to October 1, 2010 the ICD-9 discharge diagnosis code 276.6 (fluid overload) was the only applicable code in existence. On October 1, 2010, ICD-9 diagnosis
code 276.6 (fluid overload) became invalid and was replaced by more granular codes: 276.61 (transfusion associated circulatory overload) and 276.69 (other fluid
overload). For hospitalizations with a discharge date prior to October 1, 2010 the ICD-9 code 276.6 was used to construct claims-based volume overload definitions. For
hospitalizations with a discharge date on or after October 1, 2010 the ICD-9 code 276.69 was used to construct claims-based volume overload definitions
dSpecified three digit ICD-9 diagnosis categories included all existing 4th and 5th digit diagnosis codes
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dialysis treatments, validation analyses of claims-based
definitions containing of discharge diagnosis codes were
considered secondary, and results are presented in the
supplemental material.
Statistical analyses
Analyses were performed using SAS version 9.3 (SAS
Institute, Cary, NC). Data are presented as means and stand-
ard deviations or medians and interquartile ranges for con-
tinuous variables, and as frequencies and percentages forFig. 2 Computation and interpretation of validity measurescategorical variables. We computed the prevalence of
clinically-adjudicated volume overload admissions and
claims-identified volume overload admissions in the study
cohort. Using clinically adjudicated volume overload
hospitalization as the reference standard, we computed sensi-
tivity, specificity, positive predictive value (PPV), and negative
predictive value (NPV) and their exact binomial 95 % CIs for
each claims-based volume overload definition (Fig. 2).
We conducted sensitivity analyses to assess the robust-
ness of our findings. On October 1, 2010, the ICD-9
diagnosis code for fluid overload, 276.6, became invalid
Table 2 Study cohort characteristics
Characteristics All
N = 315a
Volume overloaded
at admissionb
n = 77 (24.4 %)
Not volume overloaded
at admissionb
n = 238 (75.6 %)
Age (years) 57 ± 14 57 ± 16 57 ± 14
Female 143 (45.4) 37 (48.1) 106 (44.5)
Race
Black 195 (61.9) 45 (58.4) 150 (63.0)
White 82 (26.0) 22 (28.6) 60 (25.2)
Other 38 (12.1) 10 (13.0) 28 (11.8)
Medicare as primary payer 266 (84.4) 62 (80.5) 204 (85.7)
History of diabetesc 119 (37.8) 30 (39.0) 89 (37.4)
History of hypertensionc 217 (68.9) 64 (83.1) 153 (64.3)
History of arterial diseasec 150 (47.6) 43 (55.8) 107 (45.0)
History of heart failurec 143 (45.4) 60 (77.9) 83 (34.9)
Length of hospital stay (days)d 4 (2–8) 3 (2–6) 4 (2–8)
Admitting service
Medicine 257 (81.6) 74 (96.1) 183 (76.9)
Surgery 58 (18.4) 3 (3.9) 55 (23.1)
# of billed ICD-9 discharge diagnosis codes 14 (11–19) 16 (12–21) 13 (10–18)
Dialysis CPT procedure code billed on day of
admission or the following daye
150 (48.5)
[N = 309]
42 (56.0)
[n = 75]
108 (46.2)
[n = 234]
Recent TTE ejection fractionf
< 35 % 4 (6.1) 3 (21.4) 1 (1.9)
35–54 % 30 (45.5) 4 (28.6) 27 (50.0)
≥ 55 % 32 (48.5)
[N = 66]
7 (50.0)
[n = 14]
25 (48.1)
[n = 52]
Values presented as mean ± standard deviation, median (quartile 1 – quartile 3) or n (%)
Abbreviations: CPT Current Procedural Terminology, ICD-9 International Classification of Diseases, Ninth Revision, TTE transthoracic echocardiogram
aExcept where noted
bVolume overload status at hospital admission based on clinical adjudication
cComorbid conditions were captured using all available administrative data occurring before the sampled hospitalization. ICD-9 codes for: diabetes included
250.xx; hypertension included 401.xx-405.xx (except 402.11), 402.91, 404.11, 404.13, 404.91, 404.93; arterial disease included 410.xx, 414.0x, 429.2x, 429.5x,
429.7x, 440.x, 440.2x, 440.3x, 440.8x, 440.9x, 443.9x; and heart failure included 398.91, 402.x1, 404.x1, 404.x3, 428.xx
dLength of hospital stay was computed as the discharge date minus the admission date. Patients admitted and discharged on the same day were assigned a
length of stay = 0.5 days
eSix patients were admitted and discharged on the same day and were excluded from this computation because we were unable to determine if they received
dialysis on the day following admission using inpatient administrative claims data. Dialysis CPT procedure codes used to identify inpatient dialysis treatments
include: 90935, 90937, 90945 and 90947
fTTE conducted ≤1 year before sampled hospital admission
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fusion associated circulatory overload) and 276.69 (other
fluid overload). Thus, we repeated validity assessments
in a cohort restricted to patients admitted on or after
October 1, 2010. Second, since most administrative
claims analyses of U.S. hemodialysis patients are con-
ducted in Medicare-based databases, we repeated valid-
ity assessments in a cohort restricted to patients with
Medicare as their primary insurer.
Results
Cohort characteristics
Study cohort characteristics are displayed in Table 2. In
the 315 patient cohort, the mean age was 57 ± 14 years,172 (54.6 %) were male, 195 (61.9 %) were black, 119
(37.8 %) had diabetes and 143 (45.4 %) had heart failure.
The study cohort was similar to the U.S hemodialysis
population in terms of age and sex. Consistent with
regional demographics, the study cohort had a higher
proportion of black patients compared to a broader,
national cohort [1]. The median (quartile 1 – quartile
3) length of admission was 4 (2–8) days. Of the 315
sampled admissions, 77 (24.4 %) were clinically adju-
dicated as volume overload hospitalizations. Com-
pared to patients without volume overload at
admission, patients with volume overload were more
likely to have a history of hypertension, coronary ar-
tery disease and heart failure.
Fig. 3 (See legend on next page.)
Assimon et al. BMC Nephrology  (2016) 17:173 Page 6 of 11
(See figure on previous page.)
Fig. 3 Prevalence of volume overload admissions identified by administrative claims definitions. The claims-based volume overload definition numbers
on the x-axis correspond to the following definitions: 1) fluid overload; 2) pulmonary edema; 3) heart failure; 4) fluid overload or pulmonary edema; 5)
fluid overload or pleural effusion, 6) fluid overload or heart failure; and 7) fluid overload, pulmonary edema or heart failure. The total bar height
(light gray portion+ dark gray portion) represents the prevalence of volume overload admissions in the study cohort identified using the specified
claims-based definitions. Panel a depicts prevalence estimates when claims-based definitions were constructed considering ICD-9 discharge diagnosis
codes in any position. Panel b depicts prevalence estimates when claims-based definitions were constructed considering discharge diagnosis codes in
the primary position only. Panel c depicts prevalence estimates when claims-based definitions were constructed considering discharge diagnosis codes
in the primary or leading secondary position. Abbreviations: ICD-9, International Classification of Diseases, Ninth Revision
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administrative claims
The prevalence of volume overload hospitalizations dif-
fered across administrative claims-based definitions (Fig. 3).
In primary analyses, when definitions were constructed
considering diagnosis codes in any billing position, vol-
ume overload admission prevalence ranged from 4.1 %
(definition 2, pulmonary edema) to 37.1 % (definition 7,Table 3 Validity of administrative claims definitions for volume over
Claims-based definition n (%)a SENS
ICD-9 discharge codes could be in any position
1. Fluid overload 30 (9.5) 32.5
2. Pulmonary edema 13 (4.1) 11.7
3. Heart failure 87 (27.6) 51.9
4. Fluid overload or pulmonary edema 39 (12.4) 40.3
5. Fluid overload or pleural effusion 39 (12.4) 41.6
6. Fluid overload or heart failure 111 (35.2) 76.6
7. Fluid overload, pulmonary edema or heart failure 117 (37.1) 81.8
ICD-9 discharge codes could be in primary position only
1. Fluid overload 5 (1.6) 6.5
2. Pulmonary edema 5 (1.6) 6.5
3. Heart failure 10 (3.2) 11.7
4. Fluid overload or pulmonary edema 10 (3.2) 13.0
5. Fluid overload or pleural effusion 6 (1.9) 6.5
6. Fluid overload or heart failure 15 (4.8) 18.2
7. Fluid overload, pulmonary edema or heart failure 20 (6.3) 24.7
ICD-9 discharge codes could be in primary or leading secondary positions
1. Fluid overload 5 (1.6) 6.5
2. Pulmonary edema 7 (2.2) 9.1
3. Heart failure 15 (4.8) 16.9
4. Fluid overload or pulmonary edema 12 (3.8) 15.6
5. Fluid overload or pleural effusion 6 (1.9) 6.5
6. Fluid overload or heart failure 20 (6.3) 23.4
7. Fluid overload, pulmonary edema or heart failure 27 (8.6) 32.5
Abbreviations: 95 % CI 95 % confidence interval, ICD-9 International Classification of
value, SENS sensitivity, SPEC specificity
aCount (prevalence) of volume overload admissions identified by each administrativ
bValidity estimates and 95 % CIs are expressed as percentages. Clinically adjudicate
standard. In the study cohort there were 77 adjudicated volume overload admissiofluid overload, pulmonary edema or heart failure)
(Table 3). Definitions containing heart failure diagnosis
codes (definitions 3, 6, and 7) overestimated volume
overload admission prevalence, whereas definitions with-
out heart failure codes (definitions 1, 2, 4, and 5) underes-
timated prevalence. Narrower definitions (i.e. those
constructed with diagnosis codes billed in the primary
position or in the primary or leading secondary positions)load hospital admissions
(95 % CI)b SPEC (95 % CI)b PPV (95 % CI)b NPV (95 % CI)b
(22.2, 44.1) 97.9 (95.2, 99.3) 83.3 (65.3, 94.4) 81.8 (76.8, 86.1)
(5.5, 21.0) 98.3 (95.8, 99.5) 69.2 (38.6, 90.9) 77.5 (72.3, 82.1)
(40.3, 63.5) 80.3 (74.6, 85.1) 46.0 (35.2, 57.0) 83.8 (78.3, 88.3)
(29.2, 52.1) 96.6 (93.5, 98.5) 79.5 (63.5, 90.7) 83.3 (78.4, 87.5)
(30.4, 53.4) 97.1 (94.0, 98.8) 82.1 (66.5, 92.5) 83.7 (78.8, 87.9)
(65.6, 85.5) 78.2 (72.4, 83.2) 53.2 (43.4, 62.7) 91.2 (86.4, 94.7)
(71.4, 89.7) 77.3 (71.5, 82.5) 53.8 (44.4, 63.1) 92.9 (88.4, 96.1)
(2.1, 14.5) 100.0 (98.5, 100.0) 100.0 (47.8, 100.0) 76.8 (71.7, 81.4)
(2.1, 14.5) 100.0 (98.5, 100.0) 100.0 (47.8, 100.0) 76.8 (71.7, 81.4)
(5.5, 21.0) 99.6 (97.7, 100.0) 90.0 (55.5, 99.7) 77.7 (72.6, 82.3)
(6.4, 22.6) 100.0 (98.5, 100.0) 100.0 (69.2, 100.0) 78.0 (73.0, 82.6)
(2.1, 14.5) 99.6 (97.7, 100.0) 83.3 (35.9, 99.6) 76.7 (71.6, 81.3)
(10.3, 28.6) 99.6 (97.7, 100.0) 93.3 (68.1, 99.8) 79.0 (73.9, 83.5)
(15.6, 35.8) 99.6 (97.7, 100.0) 95.0 (75.1, 99.9) 80.3 (75.3, 84.7)
(2.1, 14.5) 100.0 (98.5, 100.0) 100.0 (47.8, 100.0) 76.8 (71.7, 81.4)
(3.7, 17.8) 100.0 (98.5, 100.0) 100.0 (59.0, 100.0) 77.3 (72.2, 81.8)
(9.3, 27.1) 99.2 (97.0, 99.9) 86.7 (59.5, 98.3) 78.7 (73.6, 83.2)
(8.3, 25.6) 100.0 (98.5, 100.0) 100.0 (73.5, 100.0) 78.5 (73.5, 83.0)
(2.1, 14.5) 99.6 (97.7, 100.0) 83.3 (35.9, 99.6) 76.7 (71.6, 81.3)
(14.5, 34.4) 99.2 (97.0, 99.9) 90.0 (68.3, 98.8) 80.0 (75.0, 84.4)
(22.2, 44.1) 99.2 (97.0, 99.9) 92.6 (75.7, 99.1) 81.9 (77.0, 86.2)
Diseases, Ninth Revision, NPV negative predictive value, PPV positive predictive
e claims definition in the study cohort (N = 315)
d volume overload events, as outlined in Fig. 1, served as the reference
ns
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lence. All claims-based definitions for volume overload
hospitalizations comprised of discharge diagnosis and
dialysis procedure codes underestimated volume overload
prevalence (Additional file 2: Figure S1).
Validity of claims-based definitions for volume overload
admissions
Table 3 displays the number of events, sensitivity, specificity,
PPV and NPV for diagnosis code-based definitions for vol-
ume overload hospitalizations. In primary analyses consider-
ing definitions with diagnosis codes in any position, validity
estimates varied across claims-based definitions. Sensitivity
ranged from 11.7 % (definition 2, pulmonary edema) to
81.8 % (definition 7, fluid overload, pulmonary edema or
heart failure). Specificity ranged from 77.3 % (definition 7
fluid overload, pulmonary edema or heart failure) to 98.3 %
(definition 2, pulmonary edema). PPV ranged from 46.0 %
(definition 3, heart failure) to 83.3 % (definition 1, fluid over-
load). NPV ranged from 77.5 % (definition 2, pulmonary
edema) to 92.9 % (definition 7, fluid overload, pulmonary
edema or heart failure). Compared to definitions considering
ICD-9 codes in any position, definitions considering diagno-
sis codes in the primary position only, or in the primary or
leading secondary positions had higher specificity and PPV
and lower sensitivity and NPV.
Additional file 2: Table S3 displays validity estimates
from secondary analyses considering claims-based volume
definitions comprised of discharge diagnosis and dialysis
procedure codes. In general, specificity and PPV were
modestly higher, but sensitivity and NPV were commen-
surately lower when a dialysis procedure code was added
to diagnosis code-based definitions. Validity results from
cohorts restricted to patients admitted on or after October
1, 2010 (n = 287) and, separately, to patients with Medi-
care as the primary insurer (n = 266) were analogous to
full cohort results (Additional file 2: Tables S4 and S5).
Discussion
To our knowledge, this is the first study evaluating the
accuracy of administrative claims definitions for volume
overload hospitalizations in a hemodialysis population. Our
study demonstrated that clinically adjudicated volume
overload hospitalization prevalence differed from claims-
derived prevalence estimates. In general, claims-based
definitions had high specificity and low sensitivity. Our data
suggest that certain claims-based definitions for volume
overload hospitalizations could: 1) generate inaccurate
estimates of temporal trends in disease surveillance pro-
grams; 2) misestimate the contribution of volume-related
admissions to overall hemodialysis population health care
utilization costs; or 3) render inaccurate estimates in
observational studies seeking to understand how exposures
impact rates of volume overload hospitalizations.Existing data reveal that volume related-factors such as
chronic volume expansion, interdialytic weight gain, and
ultrafiltration rate contribute to the high hospitalization and
mortality rates experienced by hemodialysis patients [3, 5,
17–20]. Thus, there is growing interest in identifying, quan-
tifying and monitoring associated outcomes such as volume
overload hospitalizations. To detect cause-specific hospitali-
zations, investigators and regulators typically rely on
diagnosis and procedure codes in administrative healthcare
databases such as the USRDS. However, administra-
tive healthcare data may be inaccurate or incomplete
for a variety of reasons. First, available diagnosis and
procedure codes may not accurately identify the clin-
ical condition of interest [21, 22]. Second, medical
record documentation, coding and billing practices
may vary across healthcare providers or institutions,
creating data inconsistencies [23, 24]. Third, only a limited
number of discharge diagnosis codes per hospitalization
can be billed to insurers, possibly reducing clinical event
ascertainment. Fourth, patients could receive treatment at
a hospital or clinic without insurance filing, rendering ad-
ministrative data sources incomplete [22, 23, 25]. While
administrative databases are often the most accessible data
sources, they may not be the most accurate. Potential data
shortcomings must be considered when defining clinical
outcomes.
In claims-based studies of hemodialysis patients, investi-
gators have defined volume overload hospitalizations
using a variety of fluid-related discharge diagnosis code
combinations (e.g. fluid overload, pulmonary edema,
pleural effusion, and heart failure) in varying billing posi-
tions (Additional file 2: Table S1) [6, 10, 11]. Banerjee
et al. defined volume overload hospitalizations as the pres-
ence of a fluid overload or pulmonary edema discharge
diagnosis code (separately) in any billing position [10].
Others have employed more restrictive definitions.
Arneson and colleagues considered several fluid-related
diagnosis codes (e.g. fluid overload, pulmonary edema,
heart failure) present in the primary billing position only
[6]. Whereas Weinhandl et al. defined volume overload
hospital admissions as the presence of a fluid overload or
pleural effusion discharge diagnosis code in the primary
position only, or in the primary or leading secondary
positions (separately) [11]. Not surprisingly, we found that
broader (versus narrower) definitions identified more true
positive volume overload admission events, but did so at
the expense of capturing more false positive events. Most
notably, we observed that claims-based definitions con-
taining heart failure diagnosis codes (definitions 3, 6 and 7
with codes considered in any position) had the greatest
tendency to identify false positive events. This finding may
be attributable to the fact that some ICD-9 codes can be
used to bill for both chronic stable heart failure and acute
heart failure events.
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admissions using discharge diagnosis codes in conjunction
with dialysis procedure codes. For example, the claims-
based definition used by Arneson et al. included fluid-
related discharge diagnosis codes and also required the
presence of a dialysis procedure code billed on the day of
admission or the following day [6]. Inclusion of disease-
specific procedure codes often increases definition spe-
cificity [23]. As anticipated, when we added dialysis
procedure codes to diagnosis code-based definitions, we
observed gains in specificity paired with reductions in sen-
sitivity. However, the overall impact on validity estimates
was minimal. This finding may, in part, be attributable to
a hospital’s tendency to adhere to a patient’s outpatient
hemodialysis schedule. Based solely on schedule, regard-
less of clinical presentation, greater than a third of all pa-
tients would be expected to receive dialysis within 24 to
36 h of admission. Furthermore, Medicare billing rules
may impact the accuracy of claims-based definitions
relying on dialysis procedure codes. Hospitals cannot bill
dialysis CPT codes for treatments provided without the
physical presence of the attending physician during the
dialysis session [16]. In administrative data, this billing
rule may lead to underestimation of dialysis procedures in
academic environments where trainees supervise emer-
gent overnight or weekend dialysis without in-hospital
attending presence and in community hospitals where re-
mote nephrology coverage is common. Thus, to maximize
definition stability across clinical practice environments
and to avoid outcome misclassification related to billing
rules, it may be prudent to omit dialysis procedure CPT
codes from claims-based definitions for volume overload
hospital admissions.
Dialysis patient clinical complexity may also impact ac-
curacy of claims-defined, cause-specific hospitalizations. A
limited number of diagnosis codes can be billed for each
hospital encounter. Most often, payers reimburse hospitals
for inpatient services based upon billed Medicare Severity
Diagnosis Related Groups (MS-DRGs). The patient’s
primary (or principal) discharge diagnosis in combination
with other factors such as patient sex, discharge status,
complications and/or comorbidities documented as sec-
ondary discharge diagnoses, medical procedures performed,
and length of stay, determine the assigned MS-DRG and
corresponding level of reimbursement. Hemodialysis
patients often have multiple comorbidities and are treated
for numerous clinical conditions during hospitalizations,
resulting in a wide range of potential discharge diagnoses
from which to choose for coding and billing purposes.
Medicare policies allow hospitals to preferentially select
discharge diagnosis codes to maximize payment as long as
they are supported by adequate medical record documenta-
tion [26]. The tendency of heart failure-based definitions to
identify false positive volume overload admissions may beexplained, in part, by a health system’s preference for cod-
ing more resource intensive conditions or comorbidities
such as heart failure. Such practices likely vary across
healthcare and reimbursement settings.
The ideal claims-based definition for volume overload
hospital admissions would have perfect sensitivity (i.e. it
would not capture any false negative events) and perfect
specificity (i.e. it would not capture any false positive
events). As claims-based definitions for clinical event
identification are often imperfect, investigators must
weigh the advantages and disadvantages of employing
more sensitive versus more specific outcome definitions.
Study objectives should drive this decision. More sensitive
outcome definitions may be preferred in scenarios where
enhanced inclusiveness is desired (e.g. epidemiologic
surveillance studies) and when generalizability is import-
ant (e.g. quality assessment initiatives) [27, 28]. We
demonstrated that claims-based volume overload admis-
sion definitions with poor sensitivity (<50.0 %) led to
systematic underestimation of the volume-related hospital
admission burden. This finding suggests that existing
national prevalence estimates and temporal trends of
volume-related hospitalizations may be conservative. On
the other hand, more specific outcome definitions may be
favored in observational studies examining exposure–out-
come associations via relative effect measures. In the
setting of non-differential outcome misclassification,
implementation of claims-based volume overload admis-
sion outcome definitions with perfect specificity will
generate unbiased risk ratio estimates [29]. Consideration
of definition PPV and NPV is also important. Positive
predictive value, like specificity, is an indicator of false
positive event ascertainment, whereas NPV, like sen-
sitivity, is an indicator of false negative event capture.
However, unlike specificity and sensitivity, generalizability
of PPV and NPV to a population other than the validation
cohort depends on the prevalence of the outcome of inter-
est in that population.
Strengths of our study include random selection of
hospital admissions enabling estimation of the full
spectrum of validity metrics, rigorous data abstraction
by two independent reviewers, and utilization of
standardized procedures for volume overload admission
adjudication. Our study also has limitations. First, we used
data from a single academic medical center. Validity
estimates may not generalize to administrative data from
hospitals with different billing and coding practices.
Reassuringly, our study had a similar frequency of billed
volume-related discharge diagnosis codes to prior investi-
gations using USRDS data [6, 10, 11]. Second, an estab-
lished, universal definition for the clinical diagnosis of
volume overload does not exist. To address this limitation,
we developed a standardized algorithm for clinical
adjudication based on guideline body-accepted clinical
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Third, we investigated inpatient volume overload hospital
admissions. Our validity estimates may not generalize to
other hospital-based encounters such as observation stays
or emergency department visits. Given that reimburse-
ment rules and billing mechanisms differ across hospital
encounter type, optimal volume overload definitions may
vary across inpatient admissions, observation stays and
emergency department visits [30, 31]. Future studies
should assess the validity of claims-based definitions for
volume-related observation and emergency department
visits. Fourth, we evaluated inpatient admissions from
January 2010 through June 2013. Our validity estimates
may not generalize to periods outside of the study
timeframe. Our modest sample size prevented evaluation
of potential temporal coding trends on claims-based
definition validity during the study period. Finally, we
studied in-center hemodialysis patients. Results should
not be extrapolated to excluded populations such as peri-
toneal dialysis or home hemodialysis patients or those
with non-dialysis dependent chronic kidney disease.
Conclusions
In conclusion, we investigated the validity of administrative
claims-based definitions for volume overload hospital ad-
missions in a cohort of maintenance hemodialysis patients.
While administrative claims databases are efficient and cost-
effective data sources, investigators and regulators must
consider the implications of misclassifying volume overload
admissions when studying, evaluating and monitoring such
events. Our results suggest that a single, universal claims-
based definition for volume overload hospitalizations may
not be appropriate for all clinical and research scenarios.
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